Delivery Order SPE2DB24D2101-SPE2DB25FKHDM

Award Date 2/25/25
Potential Completion Date 3/18/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AVEED 750 MG/3 ML vials, a specialty pharmaceutical product. The award has a ceiling value of $7,765.20 and a period of performance through November 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,123.28, is for the delivery of 4567105547 AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of February 18, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,634.70, is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product. The contract is a firm fixed-price delivery order, with a period of performance running through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AVEED 750 MG/3 ML VIAL 3ML. The firm-fixed-price contract has a ceiling value of $27,954.72 and a completion date of October 18, 2024. It is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the company. The $18,636.48 contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award is a Delivery Order valued at $7,707.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with a performance period ending on February 14, 2025. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract has a ceiling value of $15,152.80 and runs through July 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,243.36, is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,280.40 firm fixed-price contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML medical supplies. The contract has an ultimate completion date of December 16, 2024 and was awarded on November 22, 2024. This is a non-set-aside contract, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,472.40 and an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKHDM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,926.94 and a period of performance through March 18, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/27/25, 9:44 AM